Latest Period
Q1 2026
Security Snapshot
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) Institutional Ownership
CUSIP: 413197104
13F Institutional Holders and Ownership History from Q3 2020 to Q2 2026
Institutions Reporting
309
Shares (Excl. Options)
55,871,027
Price
$28.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- HRMY on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 55,871,027
- Total 13F value
- $1,565,250,414
- Portfolio coverage rank
- 0%
- Share change
- +5,676,942
- Value change
- +$137,532,909
- Number of holders
- 309
- Shares outstanding
- 57,940,610
- SEC-reported price per share
- $35.54
- Insider filing price
- $35.54
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HRMY - Harmony Biosciences Holdings, Inc. - Common Stock is tracked under CUSIP 413197104.
- 309 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 309 to 76 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,565,250,414 to $84,863,147.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 309 institutions filings for Q1 2026.
Security key
413197104
Latest holder period
Q1 2026
13F holders
309
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
HRMY full holder history
Harmony Biosciences Holdings, Inc. SEC filings
Harmony Biosciences Holdings, Inc. company facts
Harmony Biosciences Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 413197104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
HRMY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | +12% | $237,599,390 | +$27,550,901 | 6,525,663 | +13% | BlackRock, Inc. | 30 Jun 2026 |
| Marshman Fund Trust II | 11% | $178,084,462 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| FMR LLC | 5.4% | -19% | $116,481,431 | -$27,472,267 | 3,112,812 | -19% | FMR LLC | 31 Dec 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | $104,607,832 | 2,943,383 | Vanguard Portfolio Management | 30 Jun 2026 |
As of 31 Mar 2026, 309 institutional investors reported holding 55,871,027 shares of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY). This represents 96% of the company’s total 57,940,610 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 7,070,035 | -0.26% | 0% | $198,031,682 |
| FMR LLC | 5.4% | 3,157,639 | +1.4% | 0% | $88,445,461 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7% | 2,714,353 | 0% | 0% | $76,029,028 |
| AMERICAN CENTURY COMPANIES INC | 3.6% | 2,105,179 | +14% | 0.03% | $58,966,064 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 2,102,315 | 0% | 0% | $58,885,843 |
| DIMENSIONAL FUND ADVISORS LP | 3.6% | 2,076,510 | +13% | 0.01% | $58,157,110 |
| LSV ASSET MANAGEMENT | 3.5% | 2,025,143 | +22% | 0.12% | $56,724,000 |
| SG Americas Securities, LLC | 3.5% | 2,018,174 | +110% | 0.06% | $56,529,000 |
| STATE STREET CORP | 3.1% | 1,784,362 | +7.4% | 0% | $49,979,980 |
| ARMISTICE CAPITAL, LLC | 2.8% | 1,624,000 | +225% | 1.5% | $45,488,240 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.4% | 1,382,113 | -7.3% | 0.02% | $38,712,985 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,322,720 | +4.1% | 0% | $37,054,782 |
| GOLDMAN SACHS GROUP INC | 2.1% | 1,239,207 | +118% | 0% | $34,710,189 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 1,077,371 | +0.64% | 0.05% | $30,177,162 |
| MORGAN STANLEY | 1.8% | 1,031,018 | +26% | 0% | $28,878,819 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 954,359 | +312% | 0.02% | $26,731,596 |
| JPMORGAN CHASE & CO | 1.4% | 823,513 | +313% | 0% | $22,152,500 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 733,443 | +254% | 0.02% | $20,543,738 |
| AQR CAPITAL MANAGEMENT LLC | 1.2% | 716,246 | -12% | 0.01% | $20,062,050 |
| Invesco Ltd. | 1.1% | 628,247 | +39% | 0% | $17,597,198 |
| Trexquant Investment LP | 1% | 594,850 | +99% | 0.12% | $16,661,749 |
| CITADEL ADVISORS LLC | 1% | 585,623 | +39% | 0.01% | $16,403,300 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.98% | 567,115 | +24% | 0.01% | $15,884,891 |
| BNP PARIBAS FINANCIAL MARKETS | 0.94% | 545,188 | 0% | 0.01% | $15,270,716 |
| NOMURA HOLDINGS INC | 0.9% | 520,947 | +2.1% | 0.15% | $14,591,725 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q1 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,336,567 | $84,863,147 | -$9,709,620 | $36.41 | 76 |
| 2026 Q1 | 55,871,027 | $1,565,250,414 | +$137,532,909 | $28.01 | 309 |
| 2025 Q4 | 49,890,282 | $1,866,237,475 | +$93,866,889 | $37.42 | 323 |
| 2025 Q3 | 47,339,126 | $1,304,886,690 | -$112,498,749 | $27.56 | 292 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,889 | $31.60 | 276 |
| 2025 Q1 | 50,193,424 | $1,664,235,088 | -$100,697,267 | $33.19 | 267 |
| 2024 Q4 | 52,708,406 | $1,813,638,877 | +$62,320,767 | $34.41 | 244 |
| 2024 Q3 | 50,136,635 | $2,005,018,440 | +$11,121,046 | $40.00 | 231 |
| 2024 Q2 | 50,163,988 | $1,513,604,428 | +$34,652,893 | $30.17 | 218 |
| 2024 Q1 | 48,982,561 | $1,644,752,000 | +$41,053,934 | $33.58 | 206 |
| 2023 Q4 | 47,832,583 | $1,544,993,160 | -$51,074,763 | $32.30 | 219 |
| 2023 Q3 | 49,527,453 | $1,623,105,557 | -$85,461,798 | $32.77 | 203 |
| 2023 Q2 | 51,951,129 | $1,828,229,880 | +$28,751,282 | $35.19 | 207 |
| 2023 Q1 | 51,270,566 | $1,674,006,219 | -$29,571,258 | $32.65 | 213 |
| 2022 Q4 | 51,015,535 | $2,810,596,096 | +$34,893,529 | $55.10 | 238 |
| 2022 Q3 | 50,461,165 | $2,237,024,113 | +$91,703,030 | $44.29 | 195 |
| 2022 Q2 | 47,874,920 | $2,335,182,718 | +$99,684,851 | $48.77 | 173 |
| 2022 Q1 | 45,933,803 | $2,235,023,234 | +$79,981,090 | $48.65 | 168 |
| 2021 Q4 | 44,541,354 | $1,899,444,678 | +$107,131,256 | $42.64 | 138 |
| 2021 Q3 | 30,932,269 | $1,185,850,908 | +$116,456,188 | $38.33 | 99 |
| 2021 Q2 | 27,994,218 | $790,282,400 | -$7,611,822 | $28.23 | 79 |
| 2021 Q1 | 27,468,517 | $907,561,000 | -$18,485,709 | $33.04 | 55 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,367 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,000 | $33.90 | 44 |